SHLHT strives to contribute with its Research & Development in the area of Saccharide intermediates and some advanced APIs & their intermediates to a better and healthier world. Patented drugs or drugs with exclusivity continue to drive our growth. We are committed to being at the forefront of this research with the aim to provide high therapeutic value to patients.

The R&D center has a research staff of over 18 experienced professionals in teamwork, who focus on non-infringing process development, new product development, process improvement, scale-up in multi-function workshops, analytical method development, etc.

We have expertise for multi step synthesis of complex Heterocycles and also collaborate with major Universities and Research Institutes for technical support.

Our contract manufacture facilities can synthesize the mentioned compounds from lab scale to commercial scale.

APIs & intermediates>>